Jaffetilchin Investment Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-220
| Closed | -$231K | – | 1084 |
|
|
2024
Q3 | $231K | Sell |
220
-25
| -10% | -$26.3K | 0.02% | 327 |
|
|
2024
Q2 | $258K | Sell |
245
-2
| -0.8% | -$2.1K | 0.02% | 298 |
|
|
2024
Q1 | $238K | Sell |
247
-19
| -7% | -$18.3K | 0.02% | 321 |
|
|
2023
Q4 | $234K | Hold |
266
| – | – | 0.02% | 308 |
|
|
2023
Q3 | $219K | Sell |
266
-25
| -9% | -$20.6K | 0.02% | 312 |
|
|
2023
Q2 | $209K | Buy |
+291
| New | +$209K | 0.02% | 337 |
|
|
2021
Q4 | – | Sell |
-458
| Closed | -$277K | – | 375 |
|
|
2021
Q3 | $277K | Sell |
458
-903
| -66% | -$546K | 0.03% | 284 |
|
|
2021
Q2 | $696K | Buy |
1,361
+688
| +102% | +$352K | 0.05% | 217 |
|
|
2021
Q1 | $318K | Sell |
673
-183
| -21% | -$86.5K | 0.04% | 259 |
|
|
2020
Q4 | $414K | Buy |
+856
| New | +$414K | 0.06% | 184 |
|
|
2020
Q2 | – | Sell |
-604
| Closed | -$295K | – | 233 |
|
|
2020
Q1 | $295K | Buy |
+604
| New | +$295K | 0.1% | 120 |
|
|
2019
Q2 | – | Sell |
-879
| Closed | -$361K | – | 322 |
|
|
2019
Q1 | $361K | Buy |
879
+293
| +50% | +$120K | 0.08% | 192 |
|
|
2018
Q4 | $219K | Sell |
586
-2,595
| -82% | -$970K | 0.05% | 232 |
|
|
2018
Q3 | $1.29M | Sell |
3,181
-3
| -0.1% | -$1.21K | 0.27% | 65 |
|
|
2018
Q2 | $1.1M | Buy |
+3,184
| New | +$1.1M | 0.24% | 75 |
|
|
2016
Q1 | – | Sell |
-981
| Closed | -$533K | – | 235 |
|
|
2015
Q4 | $533K | Buy |
+981
| New | +$533K | 0.17% | 95 |
|
|
2013
Q3 | – | Sell |
-1,618
| Closed | -$364K | – | 191 |
|
|
2013
Q2 | $364K | Buy |
+1,618
| New | +$364K | 0.25% | 108 |
|